Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Battermann

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Anticancer Research|January 2, 2010
Concurrent versus sequential chemotherapy and radiotherapy in limited disease small cell lung cancer: a retrospective comparative studySherif Y El Sharouni, Henk B Kal, Angeliqué Barten-Van Rijbroek, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 1, 1994
The influence of respiration induced motion of the kidneys on the accuracy of radiotherapy treatment planning, a magnetic resonance imaging studyM A Moerland, A C van den Bergh, R Bhagwandien, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 30, 2008
[Practice guideline 'Prostate cancer: diagnosis and treatment']Th M de Reijke, J J Battermann, R J A van Moorselaar, et al.
Head & Neck|June 22, 1999
A prospective study on quality of life of laryngeal cancer patients treated with radiotherapyA de Graeff, R J de Leeuw, W J Ros, et al.
Radiation Oncology Investigations|January 1, 1997
Anti-tumor effects of local irradiation in combination with peritumoral administration of low doses of recombinant interleukin-2 (rIL-2)I M Jürgenliemk-Schulz, I B Renes, D H Rutgers, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 2005
Treatment of stage III-IV nasopharyngeal carcinomas by external beam irradiation and local low doses of IL-2John J L Jacobs, Gerrit J Hordijk, Ina M Jürgenliemk-Schulz, et al.
BJU International|November 11, 2010
Survival after prostate brachytherapy in patients aged 60 years and youngerKarel A Hinnen, Ellen M A Roeloffzen, Jan J Battermann, et al.
Radiation Oncology Investigations|September 24, 1999
Prognostic relevance of MIB-1 immunoreactivity, S-phase fraction, 5-bromo-2'-deoxyuridine labeling indices, and mitotic figures in gliomasH Struikmans, D H Rutgers, G H Jansen, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 1, 1997
The influence of vasculature on temperature distributions in MECS interstitial hyperthermia: importance of longitudinal controlJ F van der Koijk, J J Lagendijk, J Crezee, et al.
International Journal of Cancer|November 5, 1997
Local low-dose interleukin-2 induces systemic immunity when combined with radiotherapy of cancer. A pre-clinical studyL A Everse, I B Renes, I M Jürgenliemk-Schulz, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Anticancer Research|January 2, 2010
Concurrent versus sequential chemotherapy and radiotherapy in limited disease small cell lung cancer: a retrospective comparative studySherif Y El Sharouni, Henk B Kal, Angeliqué Barten-Van Rijbroek, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 1, 1994
The influence of respiration induced motion of the kidneys on the accuracy of radiotherapy treatment planning, a magnetic resonance imaging studyM A Moerland, A C van den Bergh, R Bhagwandien, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 30, 2008
[Practice guideline 'Prostate cancer: diagnosis and treatment']Th M de Reijke, J J Battermann, R J A van Moorselaar, et al.
Head & Neck|June 22, 1999
A prospective study on quality of life of laryngeal cancer patients treated with radiotherapyA de Graeff, R J de Leeuw, W J Ros, et al.
Radiation Oncology Investigations|January 1, 1997
Anti-tumor effects of local irradiation in combination with peritumoral administration of low doses of recombinant interleukin-2 (rIL-2)I M Jürgenliemk-Schulz, I B Renes, D H Rutgers, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 2005
Treatment of stage III-IV nasopharyngeal carcinomas by external beam irradiation and local low doses of IL-2John J L Jacobs, Gerrit J Hordijk, Ina M Jürgenliemk-Schulz, et al.
BJU International|November 11, 2010
Survival after prostate brachytherapy in patients aged 60 years and youngerKarel A Hinnen, Ellen M A Roeloffzen, Jan J Battermann, et al.
Radiation Oncology Investigations|September 24, 1999
Prognostic relevance of MIB-1 immunoreactivity, S-phase fraction, 5-bromo-2'-deoxyuridine labeling indices, and mitotic figures in gliomasH Struikmans, D H Rutgers, G H Jansen, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 1, 1997
The influence of vasculature on temperature distributions in MECS interstitial hyperthermia: importance of longitudinal controlJ F van der Koijk, J J Lagendijk, J Crezee, et al.
International Journal of Cancer|November 5, 1997
Local low-dose interleukin-2 induces systemic immunity when combined with radiotherapy of cancer. A pre-clinical studyL A Everse, I B Renes, I M Jürgenliemk-Schulz, et al.
Pageof 11